Evaluation of the cross-neutralization capacity of Thai green pit viper antivenom against venom of Myanmar green pit viper.


Journal

Toxicon : official journal of the International Society on Toxinology
ISSN: 1879-3150
Titre abrégé: Toxicon
Pays: England
ID NLM: 1307333

Informations de publication

Date de publication:
15 Apr 2020
Historique:
received: 18 09 2019
revised: 29 01 2020
accepted: 04 02 2020
pubmed: 15 2 2020
medline: 25 6 2020
entrez: 15 2 2020
Statut: ppublish

Résumé

Green pit viper (Trimeresurus sp.) bite occurred throughout Myanmar, but there is no specific antivenom produced in the country for related envenomation. Instead, Myanmar Russell's viper antivenom (Anti-MRV) was often misused because of prolonged clotting time was observed from both species. Thai green pit viper antivenom (Anti-TGPV) raised against Trimeresurus albolabris was found to be effective against venoms of more than ten Trimeresurus sp. from Thailand, Malaysia and Indonesia. The present study compared the neutralization capacities of Anti-TGPV and Anti-MRV towards the venom from T. erythrurus from Myanmar. Anti-TGPV was more efficacious than Anti-MRV in cross-neutralizing the lethal and haemorrhagic activities of the venom by a potency of a least 1.4 times higher. Although Anti-TGPV effectively cross-neutralized the coagulation activity of the venom, Anti-MRV failed to do so. Immunodiffusion and immunoblot experiments showed that Anti-TGPV cross-reacted with more protein components of the venom than Anti-MRV. In conclusion, Anti-TGPV is a better choice for patients bitten by Myanmar green pit viper, but further clinical investigation is required. The current findings highlight the development of a specific antivenom against Myanmar green pit viper venom.

Identifiants

pubmed: 32056833
pii: S0041-0101(20)30034-9
doi: 10.1016/j.toxicon.2020.02.003
pii:
doi:

Substances chimiques

Antivenins 0
Crotalid Venoms 0
Trimeresurus venoms 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

41-45

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare no conflict of interest.

Auteurs

Khin Than Yee (KT)

Biochemistry Research Division, Department of Medical Research, Yangon, 11191, Myanmar. Electronic address: khinthanyee@gmail.com.

Lwin Zar Maw (LZ)

Biochemistry Research Division, Department of Medical Research, Yangon, 11191, Myanmar.

Aung Myat Kyaw (AM)

Nutrition Research Division, Department of Medical Research, Yangon, 11191, Myanmar.

Orawan Khow (O)

Research and Development Department, Queen Saovabha Memorial Institute, The Thai Red Cross Society, Bangkok, 10330, Thailand.

Aye Win Oo (AW)

Laboratory Animal Service Division, Department of Medical Research, Yangon, 11191, Myanmar.

Tin Ko Ko Oo (TKK)

Biochemistry Research Division, Department of Medical Research, Yangon, 11191, Myanmar.

Hsu Mon Aung (HM)

Biochemistry Research Division, Department of Medical Research, Yangon, 11191, Myanmar.

Thuzar Hla Shwe (TH)

Biochemistry Research Division, Department of Medical Research, Yangon, 11191, Myanmar.

Su Myat Htwe (SM)

Biochemistry Research Division, Department of Medical Research, Yangon, 11191, Myanmar.

Zaw Myint (Z)

Administrative Division, Department of Medical Research, Yangon, 11191, Myanmar.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH